Its like a drug that, by the way, we dont even know the full side effects yet. Early GLP-1 drugs established efficacy, and highlighted gastrointestinal side effects Exenatide was the first approved GLP-1 medication by FDA in 2005 for type 2 diabetes patients
[Google Scholar] 69.Wen H, Yang HJ, An YJ, et al
Recurrent hypoglycaemic episodes necessitate urgent medication reviewdose reduction of insulin or sulfonylureas is typically required rather than discontinuation of Ozempic
Lipid metabolism was improved, including decreased SREBP1 and FAS and increased PRKaa2 and Cpt1a mRNA levels
Large glucose swings, visceral adiposity, fatty liver, and elevated fasting insulin may all signal a metabolic environment that is less favorable for long-term cognitive health
Some are legally produced and medically appropriate others are unsafe, non-compliant, or counterfeit